SPRY
ARS Pharmaceuticals, Inc.
NASDAQ · Healthcare · Biotechnology · US
$3.05
+0.00%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 1.85x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 24.24x
- Price / sales
- 2.59x
- Price / cash flow
- -1.54x
Enterprise value
- Enterprise value
- $331.1M
- EV / sales
- 2.83x
- EV / EBITDA
- -1.60x
- EV / EBIT
- -1.53x
- Market cap
- $303.3M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026